4//SEC Filing
Rhodes Jennifer J 4
Accession 0001415889-25-009073
CIK 0001070494other
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 8:03 PM ET
Size
8.8 KB
Accession
0001415889-25-009073
Insider Transaction Report
Form 4
Rhodes Jennifer J
EVP, CHIEF LEGAL OFFICER, SEC
Transactions
- Award
Restricted Stock Units
2025-03-24+30,062→ 30,062 total→ Common Stock (30,062 underlying) - Award
Stock Option (Right to Buy)
2025-03-24+102,289→ 102,289 totalExercise: $17.23Exp: 2035-03-23→ Common Stock (102,289 underlying)
Holdings
- 1,020
Common Stock
Footnotes (4)
- [F1]Represents shares acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan on November 15, 2024.
- [F2]25% of the shares subject to the Stock Option will vest and become exercisable on March 24, 2026. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F4]The restricted stock units vest in four equal annual installments beginning March 24, 2026.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001568249
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 8:03 PM ET
- Size
- 8.8 KB